Pan-European analysis shows stable, low antimicrobial resistance in most bovine and porcine respiratory tract pathogens
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index; 2 of the 11 sources its claims cite were checked for support.
Abstract
Resistance in bovine Pasteurella multocida and Mannheimia haemolytica was absent or low, except for tetracycline.
Overview
CoChat Summary
## TL;DR
This pan-European VetPath survey found that most bovine and porcine respiratory pathogens had low antimicrobial resistance in 2019–2020, with tetracycline as the main exception. Resistance patterns were broadly similar to 2009–2012 and 2015–2016, but country-to-country differences were significant for some antibiotics, especially tetracycline.
## Key findings
- In the 2019–2020 collection, the study analyzed 307 cattle isolates and 659 pig isolates; the full collection totaled 966 clinical isolates.
- Across all 929 isolates in the MDR analysis, 17 (1.8%) were multidrug-resistant; MDR was 6.2% in bovine *P. multocida* (9 isolates), 2.3% in *M. haemolytica* (3 isolates), 0.7% in porcine *A. pleuropneumoniae* (1 isolate), and 1.7% in *S. suis* (4 isolates).
- In cattle, resistance was generally low, except tetracycline: 29.7% in *P. multocida* and 19.6% in *M. haemolytica*; *H. somni* was described as fully susceptible to all tested antibiotics.
- In pigs, resistance to ceftiofur, enrofloxacin, florfenicol, and penicillin in *P. multocida*, *A. pleuropneumoniae*, and *S. suis* was absent or <3.0%, but tetracycline resistance reached 11.4% in *P. multocida*, 13.9% in *A. pleuropneumoniae*, and 83.2% in *S. suis*.
## Methods
- The study used a pan-European surveillance design within VetPath, retrospectively comparing resistance in 2019–2020 with 2009–2012 and 2015–2016.
- Samples were non-replicate nasopharyngeal/nasal or lung swabs from animals with acute respiratory signs; cattle pathogens included *P. multocida*, *M. haemolytica*, and *H. somni*, and pig pathogens included *P. multocida*, *A. pleuropneumoniae*, *G. parasuis*, *B. bronchiseptica*, and *S. suis* (with *S. suis* also from meningitis cases).
- Susceptibility testing used broth microdilution MICs against 24 antibiotics/antibiotic combinations, interpreted with CLSI veterinary breakpoints where available; time trends were tested with Mann–Whitney, and country comparisons with χ2 tests and pairwise comparisons.
## Limitations
- The paper states that some isolates came from animals with unknown clinical history and that this could bias results; it also notes that if cases were enriched for treatment failure or recurrence, resistance might appear higher than in the general population, meaning the study may be a worst-case situation and real field resistance could be lower.
- The paper states that breed, type, and size of holding were not always available.
- Evident from the text: resistance could not be classified for all antibiotics/species because CLSI breakpoints were missing for some compounds and species, limiting comparability and possibly underestimating MDR.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
2 Valid · 0 Not valid · 9 Not checked · 141 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“The obtained MIC50 values in this current study were slightly lower for several antibiotics than those in a study on 2,046 G. parasuis isolates recovered in Germany from 2006 to 2021 (Wiencek et al., 2022).”
§ Pan-European analysis shows stable, low antimicrobial resistance in most bovine and porcine respiratory tract pathogens > Discussion
What the sources say
- Supportedcites Wiencek et al., 2022 source
Results §2.1 reports 2,046 G. parasuis-positive pigs evaluated for 2006–2021, and Methods §4.1 places the sampling in Germany. Results §2.2 identifies the study’s MIC distributions, while Methods §4.4 says MIC50 values were calculated. The ‘slightly lower’ comparison is the citing authors’ comparison with their own results, not a finding attributed to Wiencek et al.; the citation correctly identifies the reference study. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The above results together with our findings (0.0 to 3.0% resistance to five compounds) are compatible with the older results of S. suis isolates from seven EU countries (Wisselink et al., 2006).”
§ Pan-European analysis shows stable, low antimicrobial resistance in most bovine and porcine respiratory tract pathogens > Discussion
What the sources say
- Supportedcites Wisselink et al., 2006 source
The Abstract identifies a study of 384 S. suis isolates from diseased pigs in seven European countries and reports that all isolates were susceptible to four tested agents. The 0.0–3.0% figure describes the citing authors’ own findings, not a result attributed to Wisselink et al. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“While H. somni and M. haemolytica isolates exhibited low resistance to spectinomycin, 22.1% resistance was observed for P. multocida.”
§ Pan-European analysis shows stable, low antimicrobial resistance in most bovine and porcine respiratory tract pathogens > Results > Cattle isolates In cattle, a total of 307 isolates were recovered from BRD cases: 145 P. multocida, 133 M. haemolytica and 29 H. somni (Supplementary Tables S4–S6). The large majority of these were susceptible to antibiotics for which a CLSI veterinary breakpoint is available. Resistance to ceftiofur was absent in all three organisms. For amoxicillin and cefquinome, no CLSI breakpoints are available. Amoxicillin shows a bimodal MIC distribution for M. haemolytica, suggesting the development of resistance in some isolates, whereas one P. multocida isolate had a distinctly higher MIC value. In contrast, MIC distribution for amoxicillin/clavulanic acid was monomodal, as applies to cefquinome and ceftiofur. The bovine isolates ranged in their colistin MICs between ≤0.06 and 16 μg mL−1 with MIC50 and MIC90 values of 0.25 and 0.25–2 μg mL−1, respectively. The MIC distributions for marbofloxacin were similar to that of enrofloxacin and danofloxacin, for which clinical resistance was low (0.8–2.8%). Similarly, resistance to florfenicol was low (2.1–2.3%) for the isolates from both species. The highest resistance percentage was observed for tetracycline at 29.7% for P. multocida and 19.6% for M. haemolytica, whereas resistance of H. somni was 3.5%. All H. somni isolates were susceptible to second-generation macrolides gamithromycin, tildipirosin and tulathromycin, whereas the resistance for the other two bovine pathogens varied between 1.5 and 11.0%. MIC values for the older macrolide tilmicosin were similar, whereas MICs for tylosin were markedly higher for P. multocida and M. haemolytica. For both species, MIC90 values were 16–128 μg mL−1 for tiamulin and lincomycin, while both compounds showed markedly lower MIC90 values for H. somni (0.5 and ≤4 μg mL−1, respectively). Lincomycin/spectinomycin and trimethoprim/sulfamethoxazole exhibited broad multimodal MIC patterns. While H. somni and M. haemolytica isolates exhibited low resistance to spectinomycin, 22.1% resistance was observed for P. multocida.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Resistance to tiamulin amounted to 2.0% in A. pleuropneumoniae; the only species where a breakpoint for tiamulin has been set.”
§ Pan-European analysis shows stable, low antimicrobial resistance in most bovine and porcine respiratory tract pathogens > Results > Pig isolates In total 659 isolates were recovered from SRD cases: 149 P. multocida, 151 A. pleuropneumoniae, 37 G. parasuis, 90 B. bronchiseptica from respiratory infections and 232 S. suis from respiratory tract infections (79 isolates) or meningitis infections (153 isolates) (Supplementary Tables S7–S11). With respect to the three primary species P. multocida, A. pleuropneumoniae and S. suis, resistance to the antibiotics tested was zero to low (0.0–5.3%), except for tetracycline where 11.4% of P. multocida, 13.9% of A. pleuropneumoniae and 83.2% of S. suis were resistant, and tilmicosin (11.3% resistant for A. pleuropneumoniae). Similarly, the percentage of isolates classified as intermediate was 0.0–7.3% for P. multocida, A. pleuropneumoniae and S. suis, except for tetracycline (13.4, 2.0 and 12.1% resistance, respectively). Few Pasteurella, Actinobacillus and S. suis isolates were out of the wild-type distribution for amoxicillin. Remarkably, for these three species the amoxicillin/clavulanic acid MICs showed a narrower range than for amoxicillin. MIC distributions of cefquinome and ceftiofur were similar, and resistance to ceftiofur was only observed for four S. suis isolates (1.7% resistance) (no CLSI breakpoints available for cefquinome). The colistin MIC distributions were primarily monomodal for P. multocida and A. pleuropneumoniae; for S. suis very high colistin MIC values exceeding 32 μg mL−1 were observed, which is in accordance with the intrinsic resistance of S. suis to colistin. MIC values for the three fluoroquinolones were similarly distributed. Almost all (>96.0%) P. multocida, and A. pleuropneumoniae isolates were susceptible to tulathromycin and tildipirosin. Low levels of tilmicosin resistance were observed for P. multocida (0.7%) and a moderate level for A. pleuropneumoniae (11.3%). For S. suis, the MIC distributions for tilmicosin, tylosin, and lincomycin were clearly bimodal, indicating acquired resistance among the isolates; the separation between the susceptible and resistant population was absent or less clear for P. multocida and A. pleuropneumoniae. Resistance to tiamulin amounted to 2.0% in A. pleuropneumoniae; the only species where a breakpoint for tiamulin has been set. Trimethoprim/sulfamethoxazole exhibited very wide, multimodal MIC distributions. Several isolates of P. multocida and S. suis had distinctly higher MICs to spectinomycin (>512 μg mL−1), indicating acquired resistance to this compound. Among the five porcine pathogens, MICs of B. bronchiseptica were the highest and those of G. parasuis the lowest, but for individual antibiotics there were several exceptions. For B. bronchiseptica interpretive criteria are available for four antimicrobial agents allowing some data interpretation. Susceptibility results are extremely variable (Supplementary Table S10). All B. bronchiseptica isolates were resistant to amoxicillin, and 51.1% were resistant to florfenicol whereas 48.9% were florfenicol-intermediate susceptible. For both compounds none of the isolates was susceptible. In contrast, the isolates were merely susceptible to the macrolide antibiotics tildipirosin and tulathromycin. The lack of defined CLSI breakpoints for G. parasuis hampered a comparison of the percentages of resistance to the other porcine pathogens.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All H. somni isolates were susceptible to second-generation macrolides gamithromycin, tildipirosin and tulathromycin, whereas the resistance for the other two bovine pathogens varied between 1.5 and 11.0%.”
§ Pan-European analysis shows stable, low antimicrobial resistance in most bovine and porcine respiratory tract pathogens > Results > Cattle isolates In cattle, a total of 307 isolates were recovered from BRD cases: 145 P. multocida, 133 M. haemolytica and 29 H. somni (Supplementary Tables S4–S6). The large majority of these were susceptible to antibiotics for which a CLSI veterinary breakpoint is available. Resistance to ceftiofur was absent in all three organisms. For amoxicillin and cefquinome, no CLSI breakpoints are available. Amoxicillin shows a bimodal MIC distribution for M. haemolytica, suggesting the development of resistance in some isolates, whereas one P. multocida isolate had a distinctly higher MIC value. In contrast, MIC distribution for amoxicillin/clavulanic acid was monomodal, as applies to cefquinome and ceftiofur. The bovine isolates ranged in their colistin MICs between ≤0.06 and 16 μg mL−1 with MIC50 and MIC90 values of 0.25 and 0.25–2 μg mL−1, respectively. The MIC distributions for marbofloxacin were similar to that of enrofloxacin and danofloxacin, for which clinical resistance was low (0.8–2.8%). Similarly, resistance to florfenicol was low (2.1–2.3%) for the isolates from both species. The highest resistance percentage was observed for tetracycline at 29.7% for P. multocida and 19.6% for M. haemolytica, whereas resistance of H. somni was 3.5%. All H. somni isolates were susceptible to second-generation macrolides gamithromycin, tildipirosin and tulathromycin, whereas the resistance for the other two bovine pathogens varied between 1.5 and 11.0%. MIC values for the older macrolide tilmicosin were similar, whereas MICs for tylosin were markedly higher for P. multocida and M. haemolytica. For both species, MIC90 values were 16–128 μg mL−1 for tiamulin and lincomycin, while both compounds showed markedly lower MIC90 values for H. somni (0.5 and ≤4 μg mL−1, respectively). Lincomycin/spectinomycin and trimethoprim/sulfamethoxazole exhibited broad multimodal MIC patterns. While H. somni and M. haemolytica isolates exhibited low resistance to spectinomycin, 22.1% resistance was observed for P. multocida.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
91 more claims
Create a free account to see all 152 claims and every source verdict.
- It may state two separate claims as one. 31
- Probably not a substantial claim. 27
- The quote only partly states this claim. 2
Citations
Cites
Defining and combating antibiotic resistance from One Health and Global Health perspectives
Hernando-Amado, S., Coque, T. M., Baquero, F., & Martínez, J. L. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0503-9 · Cited by 1,224
Tang, K. L., Caffrey, N. P., Nóbrega, D. B., Cork, S. C., Ronksley, P. E., Barkema, H. W., Polachek, A. J., Ganshorn, H., Sharma, N., Kellner, J. D., et al. (2017) · The Lancet Planetary Health · doi:10.1016/s2542-5196(17)30141-9 · Cited by 942 · cited 1×
“Although AMR-associated foodborne and zoo-notic bacterial pathogens are known to transfer between animals and humans, it remains unclear whether the use of antimicrobials in farm animals directly drives AMR in humans (Tang et al., 2017; Martak et al., 2022).”
Ma, F., Xu, S., Tang, Z., Li, Z., & Zhang, L. (2021) · Biosafety and Health · doi:10.1016/j.bsheal.2020.09.004 · Cited by 377 · cited 1×
“The One Health approach emphasizes the standardization of surveillance methods for AMR across nations, and encourages countries to implement domestic action plans to monitor and to assess AMR patterns of clinical isolates (Boqvist et al., 2018; Ma et al., 2021; World Health Organization, 2025).”
Sweeney, M. T., Lubbers, B. V., Schwarz, S., & Watts, J. L. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky043 · Cited by 324
(2019) · Wiley eBooks · doi:10.1002/9781119350927 · Cited by 302
Assessing the antimicrobial susceptibility of bacteria obtained from animals
Schwarz, S., Silley, P., Simjee, S., Woodford, N., van Duijkeren, E., Johnson, A. P., & Gaastra, W. (2010) · Veterinary Microbiology · doi:10.1016/j.vetmic.2009.12.013 · Cited by 236 · cited 3×
“It is, therefore, important to present the MIC frequency distributions (Supplementary Tables S4–S11) to allow retrospective data interpretation (Schwarz et al., 2010).”
Self-citationSegura, M., Aragon, V., Brockmeier, S., Gebhart, C., Greeff, A., Kerdsin, A., O’Dea, M., Okura, M., Saléry, M., Schultsz, C., et al. (2020) · Pathogens · doi:10.3390/pathogens9050374 · Cited by 187 · cited 1×
“…major respiratory tract pathogen responsible for pneumonia in pigs, can also cause a variety of other diseases including meningitis, arthritis, peri-and endocarditis, polyserositis, septicemia, abortion and sudden death (Segura et al., 2020; Dechêne-Tempier et al., 2021; Vilaró et al., 2025).”
Genomic signatures of human and animal disease in the zoonotic pathogen Streptococcus suis
Weinert, L. A., Chaudhuri, R. R., Wang, J., Peters, S. E., Corander, J., Jombart, T., Baig, A., Howell, K. J., Vehkala, M., Välimäki, N., et al. (2015) · Nature Communications · doi:10.1038/ncomms7740 · Cited by 170 · cited 1×
“Some pathogenic S. suis strains have zoonotic potential, causing meningitis in humans (Weinert et al., 2015).”
(EFSA), E. F. S. A., & European Medicines Agency (EMA) (2024) · EFSA Journal · doi:10.2903/j.efsa.2024.8589 · Cited by 151
Garch, F. E., de Jong, A., Simjee, S., Moyaert, H., Klein, U., Ludwig, C., Marion, H., Haag‐Diergarten, S., Richard‐Mazet, A., Thomas, V. M., et al. (2016) · Veterinary Microbiology · doi:10.1016/j.vetmic.2016.04.009 · Cited by 146
Self-citationAntibiotic resistance in porcine pathogenic bacteria and relation to antibiotic usage
Holmer, I., Salomonsen, C. M., Jorsal, S. E. L., Astrup, L. B., Jensen, V. F., Høg, B. B., & Pedersen, K. (2019) · BMC Veterinary Research · doi:10.1186/s12917-019-2162-8 · Cited by 131 · cited 2×
“In a Danish study of A. pleuropneumoniae collected in the study period 2004–2017, almost all isolates were susceptible to all compounds tested including ceftiofur, ciprofloxacin, florfenicol, tiamulin, and the macrolides tilmicosin and tulathromycin (Holmer et al., 2019).”
Food safety challenges and One Health within Europe
Boqvist, S., Söderqvist, K., & Vågsholm, I. (2018) · Acta veterinaria Scandinavica · doi:10.1186/s13028-017-0355-3 · Cited by 121
de la Fuente, A. J. M., Tucker, A. W., Navas, J., Blanco, M., Morris, S. J., & Gutiérrez-Martín, C. B. (2006) · Veterinary Microbiology · doi:10.1016/j.vetmic.2006.10.014 · Cited by 94
Martak, D., Henriot, C. P., & Hocquet, D. (2024) · Infectious Diseases Now · doi:10.1016/j.idnow.2024.104895 · Cited by 92 · cited 1×
“Hence, a One Health approach is required to combat the spread of antimicrobial-resistant organisms in animals, the environment, and in humans in the community and hospital settings (Hernando-Amado et al., 2019; Martak et al., 2024; ECDC, EFSA, EMA, 2024; World Health Organization, 2024).”
Mader, R., Damborg, P., Amat, J.-P., Bengtsson, B., Bourély, C., Broens, E. M., Busani, L., Crespo-Robledo, P., Filippitzi, M.-E., Fitzgerald, W., et al. (2021) · Eurosurveillance · doi:10.2807/1560-7917.es.2021.26.4.2001359 · Cited by 89 · cited 2×
“Moreover, they are dependent on political commitment and sustained funding (Mader et al., 2021).”
Wisselink, H. J., Veldman, K. T., Van den Eede, C., Salmon, S. A., & Mevius, D. J. (2006) · Veterinary Microbiology · doi:10.1016/j.vetmic.2005.10.035 · Cited by 80
Matter, D., Rossano, A., LIMAT, S., et al. (2007) · Veterinary Microbiology · doi:10.1016/j.vetmic.2007.01.009 · Cited by 77 · cited 1×
“Similar results were reported in Switzerland, but with 8.4% resistance to tetracycline (Matter et al., 2007).”
InfluentialAntimicrobial resistance in bacteria associated with porcine respiratory disease in Australia
Dayao, D., Gibson, J. S., Blackall, P. J., et al. (2014) · Veterinary Microbiology · doi:10.1016/j.vetmic.2014.03.014 · Cited by 75
Hernandez-Garcia, J., Wang, J., Restif, O., Holmes, M. A., Mather, A. E., Weinert, L. A., Wileman, T. M., Thomson, J. R., Langford, P. R., Wren, B. W., et al. (2017) · Veterinary Microbiology · doi:10.1016/j.vetmic.2017.06.002 · Cited by 75
Dechêne-Tempier, M., Marois‐Créhan, C., Libante, V., Jouy, É., Leblond‐Bourget, N., & Payot, S. (2021) · Microorganisms · doi:10.3390/microorganisms9081765 · Cited by 75
Update on Glässer’s disease: How to control the disease under restrictive use of antimicrobials
Costa-Hurtado, M., Barba-Vidal, E., Maldonado, J., & Aragón, V. (2020) · Veterinary Microbiology · doi:10.1016/j.vetmic.2020.108595 · Cited by 74
de Jong, A., Thomas, V., Klein, U., Marion, H., Moyaert, H., Simjee, S., & Vallé, M. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2012.11.004 · Cited by 73
Self-citationAarestrup, F. M., Seyfarth, A. M., & Angen, Ø. (2004) · Veterinary Microbiology · doi:10.1016/j.vetmic.2004.02.012 · Cited by 65
Mader, R., EU-JAMRAI, Demay, C., Jouvin‐Marche, E., Ploy, M.-C., Barraud, O., Bernard, S., Lacotte, Y., Pulcini, C., Weinbach, J., et al. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab462 · Cited by 65
Antimicrobial Resistance in Bordetella bronchiseptica
Kadlec, K., & Schwarz, Š. (2018) · Microbiology Spectrum · doi:10.1128/microbiolspec.arba-0024-2017 · Cited by 60 · cited 2×
“Bordetella bronchiseptica is another organism involved in the etiology of bronchopneumonia (and atrophic rhinitis) in pigs and is also a contributing agent in the multifactorial porcine respiratory disease complex (Kadlec and Schwarz, 2018; Zhang et al., 2021).”
Garch, F. E., Youala, M., Simjee, S., Moyaert, H., Klee, R., Truszkowska, B., Rose, M., Hocquet, D., Valot, B., Morrissey, I., et al. (2020) · Veterinary Microbiology · doi:10.1016/j.vetmic.2020.108644 · Cited by 59
Self-citationStreptococcus suis in Swedish grower pigs: occurrence, serotypes, and antimicrobial susceptibility
Werinder, A., Aspán, A., Backhans, A., et al. (2020) · Acta veterinaria Scandinavica · doi:10.1186/s13028-020-00533-3 · Cited by 56 · cited 1×
“Similar data were noted in a Swedish collection of 188 S. suis isolates in grower pigs from herds with and without S. suis associated disease (Werinder et al., 2020).”
Feßler, A. T., Wang, Y., Burbick, C. R., Diaz-Campos, D., Fajt, V. R., Lawhon, S. D., Li, X.-Z., Lubbers, B. V., Maddock, K., Miller, R. A., et al. (2023) · One Health Advances · doi:10.1186/s44280-023-00024-w · Cited by 55 · cited 1×
“The importance of validated, harmonized and continuous monitoring of AMR of veterinary pathogens as a component of good stewardship has been frequently highlighted (Schwarz et al., 2010; Feßler et al., 2023; Krüger-Haker et al., 2026).”
Self-citationMonitoring of antimicrobial susceptibility of Streptococcus suis in the Netherlands, 2013–2015
van Hout, J., Heuvelink, A., & Gonggrijp, M. A. (2016) · Veterinary Microbiology · doi:10.1016/j.vetmic.2016.03.014 · Cited by 55
Martak, D., Guther, J., Verschuuren, T. D., Valot, B., Conzelmann, N., Bunk, S., Riccio, M. E., Salamanca, E., Meunier, A., Henriot, C. P., et al. (2021) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2021.07.022 · Cited by 55 · cited 1×
“Although AMR-associated foodborne and zoo-notic bacterial pathogens are known to transfer between animals and humans, it remains unclear whether the use of antimicrobials in farm animals directly drives AMR in humans (Tang et al., 2017; Martak et al., 2022).”
Prüller, S., Rensch, U., Meemken, D., Kaspar, H., Kopp, P. A., Klein, G., & Kehrenberg, C. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135703 · Cited by 52 · cited 1×
“In a study of a collection of 107 German B. bronchiseptica pig isolates (Prüller et al., 2015), 0.9% florfenicol resistance and 13.1% intermediate resistant were reported.”
InfluentialSchwarz, S., Kehrenberg, C., Salmon, S., & Watts, J. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh059 · Cited by 49
Occurrence of major and minor pathogens in calves diagnosed with bovine respiratory disease
Kudirkiene, E., Aagaard, A. K., Schmidt, L. M. B., Pansri, P., Krogh, K. M., & Olsen, J. E. (2021) · Veterinary Microbiology · doi:10.1016/j.vetmic.2021.109135 · Cited by 47 · cited 2×
“…Germany or Resapath in France, which are systematically monitoring AMR in their respective countries (GE RM -Vet, 2022; Anses, 2024), additionally, one-off studies frequently report susceptibility data (Van Hout et al., 2016; Vilaró et al., 2020; Kudirkiene et al., 2021; Hennig-Pauka et al., 2022).”
Towards a Standardized Method for Broth Microdilution Susceptibility Testing of Haemophilus parasuis
Prüller, S., Turni, C., Blackall, P. J., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01403-16 · Cited by 46 · cited 1×
“The exception was the MIC testing of G. parasuis , where antimicrobial susceptibility was assessed in cation-adjusted Mueller Hinton broth supplemented with 0.0025% NADH and 1% sterile heat-inactivated chicken serum (Prüller et al., 2017).”
InfluentialUse of a proposed antimicrobial susceptibility testing method for Haemophilus parasuis
Dayao, D., Kienzle, M., Gibson, J. S., Blackall, P. J., & Turni, C. (2014) · Veterinary Microbiology · doi:10.1016/j.vetmic.2014.06.010 · Cited by 41
Kadlec, K., Kehrenberg, C., Wallmann, J., & Schwarz, Š. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4903-4906.2004 · Cited by 39
Lizarazo, Y. A. V., Ferri, E. F. R., de la Fuente, A. J. M., et al. (2006) · American Journal of Veterinary Research · doi:10.2460/ajvr.67.4.663 · Cited by 38
Schönecker, L., Schnyder, P., Schüpbach‐Regula, G., Meylan, M., & Overesch, G. (2020) · Preventive Veterinary Medicine · doi:10.1016/j.prevetmed.2020.105182 · Cited by 38 · cited 3×
“The relatively low resistance levels to various antimicrobials contrast with the more common occurrence of resistance in a few European countries (Lachowicz-Wolak et al., 2025; Schönecker et al., 2020).”
InfluentialNedbalcová, K., & Kučerová, Z. (2013) · Acta Veterinaria Brno · doi:10.2754/avb201382010003 · Cited by 33 · cited 3×
“…of interpretation criteria developed for other host or bacterial species, as frequently applied in several of above studies (e.g., Aarestrup et al., 2004; De la Martín Fuente et al., 2007; Nedbalcová and Kučerová, 2013; Wiencek et al., 2022), may suggest an AMR issue that actually does not exist.”
InfluentialAntimicrobial Susceptibility Pattern of Porcine Respiratory Bacteria in Spain
Vilaró, A., Novell, E., Enrique-Tarancón, V., et al. (2020) · Antibiotics · doi:10.3390/antibiotics9070402 · Cited by 32 · cited 5×
“Vilaró et al. (2020) reported the susceptibility to florfenicol was close to 50%.”
InfluentialBrogden, S., Pavlović, A., Tegeler, R., et al. (2018) · Veterinary Microbiology · doi:10.1016/j.vetmic.2018.02.017 · Cited by 29
de Jong, A., Morrissey, I., Rose, M., Temmerman, R., Klein, U., Simjee, S., & Garch, F. E. (2023) · Journal of Applied Microbiology · doi:10.1093/jambio/lxad132 · Cited by 27
Self-citationHolschbach, C. L., Aulik, N., Poulsen, K., & Ollivett, T. L. (2020) · Journal of Dairy Science · doi:10.3168/jds.2019-17570 · Cited by 26 · cited 3×
“Similar findings were described for non-Euro-pean collections (Goldspink et al., 2015; Holschbach et al., 2020; Ueno et al., 2022).”
Zhang, Y., Yang, H., Guo, L., Zhao, M., Wang, F., Song, W., Hua, L., Wang, L., Liang, W., Tang, X., et al. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.672716 · Cited by 26
Antimicrobial Resistance in Isolates from Cattle with Bovine Respiratory Disease in Bavaria, Germany
Melchner, A., van de Berg, S., Scuda, N., Feuerstein, A., Hanczaruk, M. A., Schumacher, M., Straubinger, R. K., Marosevic, D., & Riehm, J. M. (2021) · Antibiotics · doi:10.3390/antibiotics10121538 · Cited by 26 · cited 4×
“The more recent German study of Melchner et al. (2021) on M. haemolytica isolates ( n = 273) reported low percentages of resistance for ceftiofur, enrofloxacin, florfenicol, penicillin and tilmicosin (0.0–3.7”
InfluentialSchwarz, Š., Alesík, E., Grobbel, M., Lübke‐Becker, A., Werckenthin, C., Wieler, L. H., & Wallmann, J. (2007) · PubMed · Cited by 25
Wallmann, J., Kaspar, H., & Kroker, R. (2004) · PubMed · Cited by 24
Hennig‐Pauka, I., Hartmann, M., Merkel, J., & Kreienbrock, L. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.802570 · Cited by 23
Kostova, V., Hanke, D., Kaspar, H., Fiedler, S., Schwarz, Š., & Krüger-Haker, H. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1356208 · Cited by 23 · cited 1×
“In a study on the genetic basis of macrolide resistance in M. haemolytica isolates it was concluded that macrolide resistance rates in Germany are very low (Kostova et al., 2024).”
Truswell, A., Laird, T. J., Jones, S. E., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03784-22 · Cited by 17 · cited 1×
“%) were only recorded for tetracycline in both studies (Dayao et al., 2014a; Truswell et al., 2023).”
Lagrange, J., Amat, J.-P., Ballesteros, C., et al. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1188423 · Cited by 17 · cited 2×
“It is also of interest to compare our results with the EARS-Vet project which aims to study cross-country resistance differences in Europe (Lagrange et al., 2023).”
Resistance of Streptococcus suis Isolates from the Czech Republic during 2018–2022
Nedbalcová, K., Kucharovičová, I., Zouharová, M., Matiašková, K., Králová, N., Brychta, M., Šimek, B., Pecha, T., Plodková, H., & Matiašovic, J. (2022) · Antibiotics · doi:10.3390/antibiotics11091214 · Cited by 16 · cited 2×
“In other studies, AMR levels of various antimicrobial agents were rather constant (Van Hout et al., 2016; Nedbalcova et al., 2022; SVARM, 2024).”
Kaspar, H., Schröer, U., & Wallmann, J. (2007) · PubMed · Cited by 16
Goldspink, L. K., Mollinger, J., Barnes, T., Groves, M., Mahony, T., & Gibson, J. (2014) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.12.008 · Cited by 15 · cited 2×
“Similar findings were described for non-Euro-pean collections (Goldspink et al., 2015; Holschbach et al., 2020; Ueno et al., 2022).”
InfluentialTeale, C. J., & Borriello, P. (2021) · Veterinary Record · doi:10.1002/vetr.201 · Cited by 15 · cited 1×
“A similar initiative has been taken by Teale and Borriello (2021), who have defined several bacterial species, antimicrobial agents and dilution ranges covering where possible both clinical breakpoints and epidemiological cut-off values (ECOFFs).”
Larsen, R., Boysen, L., Berg, J., Guardabassi, L., & Damborg, P. (2015) · Veterinary Dermatology · doi:10.1111/vde.12209 · Cited by 14 · cited 1×
“This methodological risk has been investigated by Larsen et al. (2015).”
Ueno, Y., Suzuki, K., Takamura, Y., Hoshinoo, K., Takamatsu, D., & Katsuda, K. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.1040266 · Cited by 12 · cited 2×
“Similar findings were described for non-Euro-pean collections (Goldspink et al., 2015; Holschbach et al., 2020; Ueno et al., 2022).”
Siteavu, M. I., Drugea, R. I., Pitoiu, E., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11102410 · Cited by 12
Vilaró, A., Novell, E., Enrique-Tarancón, V., Baliellas, J., & Fraile, L. J. (2023) · Porcine Health Management · doi:10.1186/s40813-023-00341-x · Cited by 11 · cited 1×
“In a more recent study based on non-suscep-tibility percentages of P. multocida isolates from 2019–2022 ( n = 536), these authors confirmed the preceding results (Vilaró et al., 2023).”
Wiencek, I., Hartmann, M., Merkel, J., Trittmacher, S., Kreienbrock, L., & Hennig-Pauka, I. (2022) · Pathogens · doi:10.3390/pathogens11070721 · Cited by 9
Lachowicz-Wolak, A., Chmielina, A., Przychodniak, I., Karwańska, M., Siedlecka, M., Klimowicz-Bodys, M. D., Dyba, K., & Rypuła, K. (2025) · Microorganisms · doi:10.3390/microorganisms13030491 · Cited by 9
Serna, C., Bernal, J. M. C., Torre‐Fuentes, L., García-Muñoz, Á., Díez‐Guerrier, A., Hernández, M., Fernández‐Garayzábal, J. F., Vela, A. I., Vázquez, M. D. C., & Álvarez, J. (2025) · Veterinary Quarterly · doi:10.1080/01652176.2025.2474220 · Cited by 9
Sweeney, M. T., Gunnett, L. A., Kumar, D. M., Lunt, B. L., Pantoja, L. G., Bade, D. J., & Machin, C. (2022) · Journal of Swine Health and Production · doi:10.54846/jshap/1282 · Cited by 8 · cited 2×
“In our study a high susceptibility to the second-generation macrolides tildipirosin and tulathromycin was observed, which is in accordance with other studies (Vilaró et al., 2020; GE RM - Vet, 2022; Sweeney et al., 2022).”
Vilaró, A., Karstensen, K. T., Serra, L., et al. (2025) · Veterinary Microbiology · doi:10.1016/j.vetmic.2025.110376 · Cited by 7 · cited 1×
“…major respiratory tract pathogen responsible for pneumonia in pigs, can also cause a variety of other diseases including meningitis, arthritis, peri-and endocarditis, polyserositis, septicemia, abortion and sudden death (Segura et al., 2020; Dechêne-Tempier et al., 2021; Vilaró et al., 2025).”
Antimicrobial Therapy in Beef Cattle
Apley, M. D., Lubbers, B. V., & Schrag, N. F. D. (2024) · doi:10.1002/9781119654629.ch29 · Cited by 1
Zhang, P., Li, C., Shang, S., et al. (2025) · Animals · doi:10.3390/ani15020164 · Cited by 1
de Jong, A., Temmerman, R., Sweeney, M. T., & El Garch, F. (2025) · Antimicrobial Food Packaging · doi:10.1016/b978-0-323-90747-7.00010-7 · Cited by 1
Self-citationKrüger-Haker, H., Maddock, K. J., & Schwarz, Š. (2026) · ASM Animal Microbiology · doi:10.1128/asmam.00019-25 · Cited by 1
Research works printed but not linked: 9
- 2018, Performance standards for antimicrobial disk and dilution susceptibility tests for Bacteria isolated from animals. CLSI standard VET01
- 2024, Performance standards for antimicrobial disk and dilution susceptibility tests for Bacteria isolated from animals. CLSI supplement VET01S
- 2024, Finnish veterinary antimicrobial resistance monitoring and consumption of antimicrobial agents
- 2024, Veterinary antibiotic resistance and sales surveillance report (UK-VARSS, 2023)
- Woolums, 2015, Ruminant respiratory system, 583
- 2015, Global action plan on antimicrobial resistance
- 2024, WHO list of medically important antimicrobials, 7th revision
- 2025, Global antibiotic resistance surveillance report 2025: WHO global antimicrobial resistance and use surveillance system (glass)
- 2021, Terrestrial animal health code, 8
Cited by
Actinobacillus pleuropneumoniae – today's perspective on advances and challenges (2017- 2026)
Hennig‐Pauka, I., Strutzberg‐Minder, K., & Langford, P. R. (2026) · BMC Veterinary Research · doi:10.1186/s12917-026-05791-3
“Most practitioners consider antibiotic resistance as a concern rather than a major practical issue, as at least in Europe, APP is susceptible to antimicrobials in general use when tested under in vitro conditions [81, 86, 96, 112, 113].”
InfluentialZhen, Z., Baihe, M., Guo, M., Yuxuan, W., & Lianrui, L. (2026) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2026.102519
Tan, M., Liu, C.-L., Zhou, Q., Yang, Q., Gao, T., Wan, M., Jiang, H., & Ji, H.-Y. (2026) · Research Square · doi:10.21203/rs.3.rs-10733930/v1
Metadata
- Authors
- de Jong, A., Temmerman, R., Rose, M., Simjee, S., El Garch, F., & on behalf of the VetPath Study Group
- Affiliations
- VetPath Study Group, CEESA
- ORCID
- Temmerman, Robin
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2026-02-23
- Volume
- 17
- Pages
- 1745115-1745115
- ISSN
- 1664-302X (ISSN-L)
- PMC
- PMC12967990
- OpenAlex
- W7131063878
- Cited by
- 3
- References
- 64
- Citations by year
- 2026: 3
- FWCI
- 12.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Microbiology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Zoetis
- Kela
- Huvepharma
- Elanco Animal Health
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Microbial infections and disease research
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- antimicrobial resistance, Pasteurella multocida, Mannheimia haemolytica, Histophilus somni, Actinobacillus pleuropneumoniae, Haemophilus parasuis, Bordetella bronchiseptica, Streptococcus suis, tetracycline resistance, macrolide resistance, multidrug resistance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.